- Novo Nordisk CEO stated that liver disease is an obvious area for the company to pursue.
- CEO stated that cardiovascular is another obvious area, despite recent setbacks.
Novo Nordisk CEO identifies liver disease and cardiovascular as key expansion areas despite recent setbacks.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.